跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Antamin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Antamin
Approved
STANDARD
Antamin
Pascual Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
46b51edf04ebc156
Company
Pascual Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
46b51edf04ebc156
Drug Approval Philippines Name
Antamin
Product Name
Antamin
Registration Number
DR-2359
Brand Name
Antamin
Generic Name
Chlorphenamine Maleate
Dosage Form
Tablet
Dosage Strength
4 mg
Manufacturer
Pascual Laboratories, Inc.
Trader
ADP Pharma Corporation
Issuance Date
24 January 2022
Expiry Date
05 April 2027
Pharmacologic Category
Antihistamines (Substituted Alkylamine)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
46b51edf04ebc156
Type
Standard
Back to Philippines FDA Approvals